Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D routine supplementation recommended by Harvard researchers -- NEJM study.

This article was originally published in The Tan Sheet

Executive Summary

VITAMIN D ROUTINE SUPPLEMENTATION "SHOULD BE CONSIDERED" because deficiency is widespread, linked to adverse effects and difficult to predict, Melissa Thomas, MD/PhD, Harvard Medical School, et al., conclude in a study on vitamin D deficiency in general medical inpatients. The researchers measured vitamin D intake, ultraviolet light exposure and risk factors for vitamin D deficiency in nearly 300 patients on a general medical ward at Massachusetts General Hospital and found that more than half were vitamin D deficient. The study, funded by grants from the National Institutes of Health and the American Kidney Fund, was published in the March 19 New England Journal of Medicine.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel